Status:
COMPLETED
Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy
Lead Sponsor:
Stanford University
Conditions:
Pregnancy Complications
Eligibility:
FEMALE
18-50 years
Brief Summary
We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyp...
Detailed Description
Pregnant patients who are undergoing inpatient betamethasone therapy as part of their clinical care will be eligible for the study. Once the clinical team and patients have agreed to pursue betamethas...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Receiving betamethasone as part of routine clinical care.
- Pregnancy between 23+5 and 35+0 weeks
Exclusion
- Less than 18 years old.
- Major fetal anomalies
- Use of steroid medications in the past 2 weeks.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01165775
Start Date
July 1 2010
End Date
December 1 2014
Last Update
September 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305